CDCA3 and bladder transitional cell carcinoma: These two assays revealed that the motility of bladder urothelial carcinoma cells was strongly impaired after the silencing of CDCA3 and indicated that the potential of CDCA3 in promoting the distant metastasis of bladder urothelial carcinoma.